- Home
- FBNC vs OGN Comparison
FBNC vs OGN Comparison
Compare FBNC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- OGN
- Stock Information
- Founded
- FBNC 1934
- OGN 1923
- Country
- FBNC United States
- OGN United States
- Employees
- FBNC N/A
- OGN N/A
- Industry
- FBNC Major Banks
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- FBNC Finance
- OGN Health Care
- Exchange
- FBNC Nasdaq
- OGN Nasdaq
- Market Cap
- FBNC 2.1B
- OGN 2.5B
- IPO Year
- FBNC N/A
- OGN N/A
- Fundamental
- Price
- FBNC $54.53
- OGN $9.44
- Analyst Decision
- FBNC Buy
- OGN Hold
- Analyst Count
- FBNC 4
- OGN 4
- Target Price
- FBNC $53.67
- OGN $18.00
- AVG Volume (30 Days)
- FBNC 314.8K
- OGN 4.9M
- Earning Date
- FBNC 10-22-2025
- OGN 08-05-2025
- Dividend Yield
- FBNC 1.77%
- OGN 0.86%
- EPS Growth
- FBNC N/A
- OGN N/A
- EPS
- FBNC 2.35
- OGN 2.69
- Revenue
- FBNC $361,053,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- FBNC $36.85
- OGN N/A
- Revenue Next Year
- FBNC $8.45
- OGN $1.02
- P/E Ratio
- FBNC $23.23
- OGN $3.51
- Revenue Growth
- FBNC N/A
- OGN N/A
- 52 Week Low
- FBNC $34.50
- OGN $8.01
- 52 Week High
- FBNC $54.65
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- FBNC 71.61
- OGN 49.73
- Support Level
- FBNC $50.75
- OGN $9.15
- Resistance Level
- FBNC $52.91
- OGN $9.48
- Average True Range (ATR)
- FBNC 1.31
- OGN 0.45
- MACD
- FBNC 0.09
- OGN 0.03
- Stochastic Oscillator
- FBNC 98.35
- OGN 56.14
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.